State of Wisconsin Investment Board’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-69,615
| Closed | -$1.64M | – | 2482 |
|
|
2023
Q4 | $1.64M | Sell |
69,615
-2,319
| -3% | -$41.3K | ﹤0.01% | 1276 |
|
|
2023
Q3 | $1.07M | Sell |
71,934
-9,381
| -12% | -$124K | ﹤0.01% | 1374 |
|
|
2023
Q2 | $890K | Buy |
81,315
+3,191
| +4% | +$29.7K | ﹤0.01% | 1502 |
|
|
2023
Q1 | $681K | Buy |
+78,124
| New | +$625K | ﹤0.01% | 1698 |
|
|
2021
Q4 | – | Sell |
-14,800
| Closed | -$54K | – | 2233 |
|
|
2021
Q3 | $54K | Sell |
14,800
-38,600
| -72% | -$152K | ﹤0.01% | 2112 |
|
|
2021
Q2 | $233K | Sell |
53,400
-115,400
| -68% | -$512K | ﹤0.01% | 2020 |
|
|
2021
Q1 | $766K | Buy |
168,800
+24,200
| +17% | +$130K | ﹤0.01% | 1441 |
|
|
2020
Q4 | $830K | Buy |
144,600
+95,000
| +192% | +$719K | ﹤0.01% | 1378 |
|
|
2020
Q3 | $359K | Buy |
49,600
+24,200
| +95% | +$129K | ﹤0.01% | 1586 |
|
|
2020
Q2 | $89K | Buy |
+25,400
| New | +$73.3K | ﹤0.01% | 1666 |
|
|
2020
Q1 | – | Sell |
-103,400
| Closed | -$203K | – | 1747 |
|
|
2019
Q4 | $203K | Hold |
103,400
| – | – | ﹤0.01% | 1581 |
|
|
2019
Q3 | $529K | Sell |
103,400
-197,121
| -66% | -$1.19M | ﹤0.01% | 1305 |
|
|
2019
Q2 | $2.15M | Buy |
300,521
+7,500
| +3% | +$84.9K | 0.01% | 1009 |
|
|
2019
Q1 | $3.89M | Sell |
293,021
-16,582
| -5% | -$176K | 0.01% | 869 |
|
|
2018
Q4 | $2.44M | Buy |
309,603
+51,600
| +20% | +$491K | 0.01% | 928 |
|
|
2018
Q3 | $2.86M | Buy |
258,003
+111,600
| +76% | +$1.39M | 0.01% | 980 |
|
|
2018
Q2 | $1.97M | Buy |
146,403
+16,600
| +13% | +$208K | 0.01% | 998 |
|
|
2018
Q1 | $1.69M | Buy |
+129,803
| New | +$1.61M | ﹤0.01% | 997 |
|
Other funds holding CBAY
State of Wisconsin Investment Board's CBAY Position: Q1 2024 in Review
State of Wisconsin Investment Board sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 69,615 shares — an estimated $1.64M sold.
State of Wisconsin Investment Board first reported a position in CBAY in Q1 2018 and held it in 18 quarters. The position peaked at $3.89M in Q1 2019. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.
- State of Wisconsin Investment Board reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
- State of Wisconsin Investment Board sold 69,615 Cymabay Therapeutics shares in Q1 2024, an estimated $1.64M.
- State of Wisconsin Investment Board first reported a position in Cymabay Therapeutics in Q1 2018 and held it in 18 quarters.
- State of Wisconsin Investment Board's Cymabay Therapeutics position peaked at $3.89M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2024, filed 14 May 2024.